You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 82 No. 4, October 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (172)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Photodynamic Properties of a Particular Hematoporphyrin Derivative

RICHARD L. LIPSON, M.D.; EDWARD J. BALDES, Ph.D.

Arch Dermatol. 1960;82(4):508-516.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1898 Oscar Raab, while a student in Tappeiner's laboratory, recognized that paramecia were sensitized to light by the aniline dye, acridine. This finding led to extensive studies by Tappeiner and Jodlbauer and their associates,9,19,-21 and to the introduction of the term "photodynamic action," used by Tappeiner in 1904.

The use of hematoporphyrin in the study of photodynamics came soon after the original studies by Raab. The first study was by Hausmann in 1908. He reported destruction of paramecia and red blood cells and described in detail the symptoms of sensitized mice on exposure to light.6-8 Pfeiffer found the same thing in guinea pigs, and in 1913 Meyer-Betz sensitized himself and reported similar symptoms which lasted two months. During subsequent years, many studies1-4 were carried out using hematoporphyrin hydrochloride prepared according to the classic method of Nencki and Zaleski. However, Schwartz and associates16,17 have found that . . . [Full Text PDF of this Article]


Author Affiliations

Rochester, Minn.

Fellow in Medicine, Mayo Foundation (Dr. Lipson); Section of Biophysics, Mayo Clinic and Mayo Foundation (Dr. Baldes). The Mayo Foundation is a part of the Graduate School of the University of Minnesota.


Footnotes

Submitted for publication April 4, 1960.

The investigation on which this report is based was supported in part by Cancer Institute Research Fellowship Grant Number CF9880.

Abridgment of thesis submitted by Dr. Lipson to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.